tm
Seeing Is Believing
tm
Seeing Is Believing
Checkmate Pharmaceuticals's activity chart (see below) currently has 7 price targets and 6 ratings on display.
Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 86 days.
Most recent stock forecast was given by KAVERI POHLMAN from BTIG on 20-Apr-2022. First documented stock forecast 01-Sep-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Sep-2020
$9
4 years 6 months 11 days ago
(20-Apr-2022)
1/2 (50%)
$5.78 (179.50%)
20
Hold Since 01-Sep-2020
$7
5 years 24 days ago
(07-Oct-2021)
1/2 (50%)
$2.71 (63.17%)
195
Buy Since 01-Sep-2020
$32
$21.5 (204.76%)
6 years 1 months 30 days ago
(01-Sep-2020)
0/1 (0%)
$17 (113.33%)
What is CMPI (Checkmate Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on CMPI (Checkmate Pharmaceuticals)?
Which analyst has the current lower performing score on CMPI (Checkmate Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CMPI (Checkmate Pharmaceuticals)?
Which analyst is the currently most bullish on CMPI (Checkmate Pharmaceuticals)?
Which analyst is the currently most reserved on CMPI (Checkmate Pharmaceuticals)?
